Type
Noon L, Lloyd A. Treating leprosy: an Erb-al remedy?. Trends in pharmacological sciences. 2007;28(3):103-5.
Type
Santos PM, Melo CM, Martins SAR, Chaves AA, Sá DSP, Santos RCR. [Study of ocular fungal microbiota in patients with Hansen's disease and in individuals who deal with them]. Arquivos brasileiros de oftalmologia. 2006;69(6):915-8.
Type
Moreira AS, Santos RCR, Bastos RR, Silva JV, Santos PM. [Conjunctival bacilloscopy in leprosy diagnosis and follow-up]. Arquivos brasileiros de oftalmologia. 2006;69(6):865-9.
Type
Husain S, Malaviya. Early nerve damage in leprosy: an electrophysiological study of ulnar and median nerves in patients with and without clinical neural deficits. Neurology India. 2007;55(1):22-6.
Type
Lawn S, Lockwood DN. Leprosy after starting antiretroviral treatment. BMJ (Clinical research ed.) [Internet]. 2007;334(7587):217-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790767/
Type
Chaya. Ocular complications of leprosy. British journal of hospital medicine. 1992;47(1):69.
Type
Rossler. Teaching and learning materials in leprosy (TALMILEP) (a joint project of ILEP--International Federation of Anti Leprosy Associations. International journal of dermatology. 1992;31(1):66-7.
Type
Mehra, Bloom, Bajardi, Grisso, Sieling, Alland, et al. A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. The Journal of experimental medicine. 1992;175(1):275-84.
Type
Meyers. Leprosy. Dermatologic clinics. 1992;10(1):73-96.
Type
Crawshaw. A piece of my mind. Requiem for an unknown leper. JAMA. 1991;266(24):3411-2.